In summary, our study revealed that the oncofetal antigen 5T4 was restrictively expressed on the surface of NPC cells and is associated with the stemness of NPCSCs, which makes it a promising target for CAR-redirected CIK-cell-based immunotherapy against NPC. This evidence concerns the gene TPBG and nasopharyngeal carcinoma.